BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 27287213)

  • 1. UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
    Creamer D; Walsh SA; Dziewulski P; Exton LS; Lee HY; Dart JKG; Setterfield J; Bunker CB; Ardern-Jones MR; Watson KMT; Wong GAE; Philippidou M; Vercueil A; Martin RV; Williams G; Shah M; Brown D; Williams P; Mohd Mustapa MF; Smith CH
    J Plast Reconstr Aesthet Surg; 2016 Jun; 69(6):e119-e153. PubMed ID: 27287213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
    Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
    Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis--A Comprehensive Review and Guide to Therapy. I. Systemic Disease.
    Kohanim S; Palioura S; Saeed HN; Akpek EK; Amescua G; Basu S; Blomquist PH; Bouchard CS; Dart JK; Gai X; Gomes JA; Gregory DG; Iyer G; Jacobs DS; Johnson AJ; Kinoshita S; Mantagos IS; Mehta JS; Perez VL; Pflugfelder SC; Sangwan VS; Sippel KC; Sotozono C; Srinivasan B; Tan DT; Tandon R; Tseng SC; Ueta M; Chodosh J
    Ocul Surf; 2016 Jan; 14(1):2-19. PubMed ID: 26549248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016 (print summary - Full guidelines available at http://dx.doi.org/10.1016/j.bjps.2016.01.034).
    Creamer D; Walsh SA; Dziewulski P; Exton LS; Lee HY; Dart JKG; Setterfield J; Bunker CB; Ardern-Jones MR; Watson KMT; Wong GAE; Philippidou M; Vercueil A; Martin RV; Williams G; Shah M; Brown D; Williams P; Mohd Mustapa MF; Smith CH
    J Plast Reconstr Aesthet Surg; 2016 Jun; 69(6):736-741. PubMed ID: 27216885
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxic epidermal necrolysis: The past, the guidelines and challenges for the future.
    Wolkenstein P; Wilson YT
    J Plast Reconstr Aesthet Surg; 2016 Jun; 69(6):733-735. PubMed ID: 27287211
    [No Abstract]   [Full Text] [Related]  

  • 6. Burn unit care of Stevens Johnson syndrome/toxic epidermal necrolysis: A survey.
    Le HG; Saeed H; Mantagos IS; Mitchell CM; Goverman J; Chodosh J
    Burns; 2016 Jun; 42(4):830-5. PubMed ID: 26810444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Parrillo SJ
    Curr Allergy Asthma Rep; 2007 Jul; 7(4):243-7. PubMed ID: 17547844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP; Bhatt AD
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update.
    Dodiuk-Gad RP; Chung WH; Valeyrie-Allanore L; Shear NH
    Am J Clin Dermatol; 2015 Dec; 16(6):475-93. PubMed ID: 26481651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Treat J
    Pediatr Ann; 2010 Oct; 39(10):667-9, 672-4. PubMed ID: 20954613
    [No Abstract]   [Full Text] [Related]  

  • 12. [News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)].
    Martínez-Cabriales SA; Gómez-Flores M; Ocampo-Candiani J
    Gac Med Mex; 2015; 151(6):777-87. PubMed ID: 26581536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management.
    Mockenhaupt M
    Semin Cutan Med Surg; 2014 Mar; 33(1):10-6. PubMed ID: 25037254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults.
    Seminario-Vidal L; Kroshinsky D; Malachowski SJ; Sun J; Markova A; Beachkofsky TM; Kaffenberger BH; Ergen EN; Mauskar M; Bridges A; Calhoun C; Cardones AR; Chen ST; Chodosh J; Cotliar J; Davis MDP; DeNiro KL; Dominguez AR; Eljure-Téllez J; Femia A; Fox LP; Guda A; Mitchell C; Mostaghimi A; Ortega-Loayza AG; Owen C; Pasieka H; Rahnama-Moghadam S; Saeed HN; Saunderson RB; Shanbhag S; Sharon VR; Strowd L; Venkatesh S; Wanat KA; Wetter DA; Worswick S; Micheletti RG
    J Am Acad Dermatol; 2020 Jun; 82(6):1553-1567. PubMed ID: 32151629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens-Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN.
    Ramien ML; Mansour D; Shear NH
    Paediatr Drugs; 2022 Jul; 24(4):307-319. PubMed ID: 35676614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stevens-Johnson Syndrom and Toxic Epidermal Necrolysis--based on literature].
    Łoboda J; Dudzik A; Chomyszyn-Gajewska M
    Przegl Lek; 2015; 72(1):35-7. PubMed ID: 26076576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction].
    Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN
    Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options.
    Worswick S; Cotliar J
    Dermatol Ther; 2011; 24(2):207-18. PubMed ID: 21410610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N
    Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink.
    Frey N; Bircher A; Bodmer M; Jick SS; Meier CR; Spoendlin J
    Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):429-436. PubMed ID: 27868282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.